Cargando…

Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma

Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC). Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients. In this r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Scott P., Song, Daniel Y., Pierorazio, Phillip M., Allaf, Mohamad E., Gorin, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658408/ https://www.ncbi.nlm.nih.gov/pubmed/26640488 http://dx.doi.org/10.1155/2015/547143

Ejemplares similares

Outcomes of partial nephrectomy in patients who meet percutaneous ablation criteria
por: Harris, Kelly T., et al.
Publicado: (2015)

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
por: Barbour, Andrew B., et al.
Publicado: (2023)

Renal Pseudoaneurysm Mimicking Local Cancer Recurrence After Partial Nephrectomy
por: Campbell, Scott P., et al.
Publicado: (2016)

Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma
por: Rowe, Steven P., et al.
Publicado: (2015)

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
por: Senger, C., et al.
Publicado: (2019)

Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: a review
por: Ray, Shagnik, et al.
Publicado: (2020)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
por: Schoenhals, Jonathan E., et al.
Publicado: (2021)

Salvage Robot-Assisted Partial Nephrectomy for the Management of Renal Cell Carcinoma Following Failed Stereotactic Radiotherapy
por: Gorin, Michael A., et al.
Publicado: (2012)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
por: Cheng, Po-Lung, et al.
Publicado: (2023)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Correlation of (99m)Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression
por: Rowe, Steven P., et al.
Publicado: (2017)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists
por: Li, Shan, et al.
Publicado: (2020)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

4540 THE IMPACT OF SURGEON AND HOSPITAL VOLUME ON 30-DAY OUTCOMES AND COST FOR RENAL CANCER SURGERY
por: Wainger, Julia, et al.
Publicado: (2020)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
por: Ji, Ren, et al.
Publicado: (2022)

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
por: Rabinowitz, Matthew J., et al.
Publicado: (2022)

Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma
por: Burgess, Laura, et al.
Publicado: (2021)

FRI146 Stereotactic Ablative Radiotherapy As A Local Valuable Therapeutic Procedure To Control Aldosterone-Secreting Adrenocortical Carcinoma
por: Mara Mermejo, Livia, et al.
Publicado: (2023)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
por: Molon, Giulio, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
por: Bae, Sun Hyun, et al.
Publicado: (2013)

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Pan, Yang-Xun, et al.
Publicado: (2020)

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
por: Kwon, Jung Hyun, et al.
Publicado: (2010)

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma
por: Liu, Feng, et al.
Publicado: (2013)

Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer
por: Jung, Jinhong, et al.
Publicado: (2015)

2542: Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis
por: Srivastava, Arnav, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fmqc2ov97r30pfkc3i1roq0bkr